Continental Resources, Inc. is an independent oil producer that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on CLR’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Continental Resources could be a solid choice for investors.
Current Quarter Estimates for CLR
In the past 30 days, three estimates have gone higher for Continental Resources while one have gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing 53 cents a share 30 days ago, to 57 cents today, a move of 7.5%.
Current Year Estimates for CLR
Meanwhile, Continental Resources’ current year figures are also looking quite promising, with seven estimates moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, increasing from $2.16 a share 30 days ago, to $2.38 today, an increase of 10.2%.
Continental Resources, Inc. Price and Consensus
Bottom Line
The stock has also started to move higher lately, adding 19.7% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank stocks here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
Image: Bigstock
Why Continental Resources (CLR) Could Be Positioned for a Surge
Continental Resources, Inc. is an independent oil producer that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing solid activity on the earnings estimate revision front as well.
These positive earnings estimate revisions suggest that analysts are becoming more optimistic on CLR’s earnings for the coming quarter and year. In fact, consensus estimates have moved sharply higher for both of these time frames over the past four weeks, suggesting that Continental Resources could be a solid choice for investors.
Current Quarter Estimates for CLR
In the past 30 days, three estimates have gone higher for Continental Resources while one have gone lower in the same time period. The trend has been pretty favorable too, with estimates increasing 53 cents a share 30 days ago, to 57 cents today, a move of 7.5%.
Current Year Estimates for CLR
Meanwhile, Continental Resources’ current year figures are also looking quite promising, with seven estimates moving higher in the past month, compared to none lower. The consensus estimate trend has also seen a boost for this time frame, increasing from $2.16 a share 30 days ago, to $2.38 today, an increase of 10.2%.
Continental Resources, Inc. Price and Consensus
Continental Resources, Inc. Price and Consensus | Continental Resources, Inc. Quote
Bottom Line
The stock has also started to move higher lately, adding 19.7% over the past four weeks, suggesting that investors are starting to take note of this impressive story. So investors may definitely want to consider this Zacks Rank #1 (Strong Buy) stock to profit in the near future. You can see the complete list of today’s Zacks #1 Rank stocks here.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>